Calendrier des promotions Celcuity Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.Paramètres de base
IPO date
2017-09-20
ISIN
US15102K1007
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 0 | 0 |
P/BV | 4.48 | 4 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -51.23 | 0 |
ROE | -87.54 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | -0.8648 | 10 |
Debt/Ratio | 0.3996 | 10 |
Debt/Equity | 1.12 | 8 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 0 | 0 |
Rentabilité Ebitda, % | 1092.28 | 10 |
Rentabilité EPS, % | 220.1 | 10 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 12.11 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 12.92 $ | 0 $ | 0 $ | -6.27 % | 0 % | 0 % |
common.calendar.number_days.30d | 10.44 $ | 12.11 $ | 13.05 $ | 16 % | 0 % | 0 % |
common.calendar.number_days.90d | 9.23 $ | 8.21 $ | 13.05 $ | 31.2 % | 0 % | 0 % |
common.calendar.number_days.180d | 12.59 $ | 8.21 $ | 13.16 $ | -3.81 % | 0 % | 0 % |
common.calendar.number_days.1y | 16.59 $ | 8.21 $ | 19.15 $ | -27 % | 0 % | 0 % |
common.calendar.number_days.3y | 10.04 $ | 7.55 $ | 21.6 $ | 20.62 % | 0 % | 0 % |
common.calendar.number_days.5y | 5.28 $ | 5.1 $ | 30.93 $ | 129.36 % | 0 % | 0 % |
common.calendar.number_days.10y | 4.42 $ | 4.42 $ | 30.93 $ | 273.98 % | 0 % | 0 % |
common.calendar.number_days.ytd | 11.95 $ | 8.21 $ | 13.62 $ | 1.34 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
Jacob Forward ETF | 0.85997 | 26.5 | 0.75 |
iShares Morningstar Small-Cap Growth ETF | 0.00891 | 601.87 | 0.06 |
iShares Morningstar Small-Cap ETF | 0.00435 | 328.78 | 0.25 |
0,29 | 319,05 | 0,35 |
---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Brian F. Sullivan | Co-Founder, Chairman & CEO | 478.12k | 1962 (63 année) |
Dr. Lance G. Laing Ph.D. | Co-Founder, Chief Science Officer, VP, Secretary & Director | 389.55k | 1962 (63 année) |
Ms. Vicky Hahne | Chief Financial Officer | 281.59k | 1966 (59 années) |
Dr. John R. MacDonald Dabt, Ph., Ph.D. | Senior Vice President of R&D | N/A | 1955 (70 années) |
Ms. Sheri Smith | Acting Head of Clinical Operations | N/A | |
Mr. Igor Gorbatchevsky M.D. | Chief Medical Officer | N/A | |
Mr. Eldon C. Mayer III, M.B.A. | Chief Commercial Officer | N/A | 1961 (64 année) |
Dr. Charlotte Moser M.B.A., M.D., M.Sc., Ph.D. | Senior Vice President of Clinical Development |
Informations sur l'entreprise
Adresse: United States, Minneapolis. MN, 16305–36th Avenue North - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.celcuity.com
Site web: https://www.celcuity.com